# Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC

> **NCT06900478** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Hua Li** · enrollment: 25 (estimated)

## Conditions studied

- Hepatocarcinoma

## Interventions

- **DRUG:** Icariin Soft Capsules+TACE

## Key facts

- **NCT ID:** NCT06900478
- **Lead sponsor:** Hua Li
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-30
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-02-28
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06900478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06900478, "Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06900478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*